@ag76_biotech Two entirely different platforms. $INO's data wasn't strong enough &amp; they have manufacturing issues w/suppliers. $MRNA has shown solid early data for ZIKA, CMV and COVID-19; with the solid $PFE / $BNTX data, good news for mRNA platform tech continues $ARWR, $TBIO $ARCT, etc.